Guizhou Sanli Pharmaceutical Co.,Ltd (SHA:603439)
China
· Delayed Price · Currency is CNY 11.69
-0.09 (-0.76%)
Mar 11, 2026, 3:00 PM CST
SHA:603439 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 10, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 4,768 | 5,205 | 7,738 | 5,637 | 6,483 | 8,252 | Upgrade
|
| Market Cap Growth | -8.12% | -32.74% | 37.27% | -13.05% | -21.44% | - | Upgrade
|
| Enterprise Value | 5,318 | 5,445 | 7,421 | 5,342 | 6,161 | 7,991 | Upgrade
|
| Last Close Price | 11.78 | 12.63 | 18.08 | 13.06 | 15.03 | 18.98 | Upgrade
|
| PE Ratio | 29.48 | 18.99 | 26.44 | 28.01 | 42.58 | 87.84 | Upgrade
|
| Forward PE | - | 13.81 | 26.53 | - | - | - | Upgrade
|
| PS Ratio | 2.75 | 2.43 | 4.73 | 4.69 | 6.91 | 13.09 | Upgrade
|
| PB Ratio | 3.08 | 3.26 | 4.53 | 4.55 | 6.28 | 8.40 | Upgrade
|
| P/TBV Ratio | 6.56 | 6.88 | 11.37 | 5.81 | 6.41 | 8.51 | Upgrade
|
| P/FCF Ratio | 127.82 | 84.12 | 46.07 | 32.51 | 50.27 | 715.14 | Upgrade
|
| P/OCF Ratio | 69.94 | 48.61 | 27.97 | 19.22 | 41.82 | 130.48 | Upgrade
|
| EV/Sales Ratio | 3.06 | 2.54 | 4.54 | 4.45 | 6.56 | 12.68 | Upgrade
|
| EV/EBITDA Ratio | 18.92 | 13.54 | 24.44 | 24.24 | 37.78 | 70.73 | Upgrade
|
| EV/EBIT Ratio | 29.86 | 16.58 | 27.77 | 26.11 | 40.56 | 76.20 | Upgrade
|
| EV/FCF Ratio | 142.56 | 88.00 | 44.18 | 30.81 | 47.77 | 692.48 | Upgrade
|
| Debt / Equity Ratio | 0.52 | 0.38 | 0.33 | 0.17 | 0.19 | 0.20 | Upgrade
|
| Debt / EBITDA Ratio | 2.87 | 1.50 | 1.83 | 0.93 | 1.23 | 1.77 | Upgrade
|
| Debt / FCF Ratio | 21.65 | 9.81 | 3.30 | 1.19 | 1.55 | 17.33 | Upgrade
|
| Net Debt / Equity Ratio | 0.31 | 0.07 | -0.04 | -0.34 | -0.43 | -0.39 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.72 | 0.27 | -0.22 | -1.93 | -2.71 | -3.36 | Upgrade
|
| Net Debt / FCF Ratio | 12.93 | 1.74 | -0.40 | -2.45 | -3.43 | -32.93 | Upgrade
|
| Asset Turnover | 0.59 | 0.70 | 0.69 | 0.75 | 0.71 | 0.63 | Upgrade
|
| Inventory Turnover | 1.67 | 2.63 | 3.20 | 3.64 | 4.07 | 4.14 | Upgrade
|
| Quick Ratio | 1.06 | 1.16 | 1.56 | 1.94 | 2.79 | 3.30 | Upgrade
|
| Current Ratio | 1.45 | 1.46 | 1.78 | 2.14 | 3.05 | 3.49 | Upgrade
|
| Return on Equity (ROE) | 9.67% | 16.94% | 20.01% | 16.91% | 14.76% | 11.51% | Upgrade
|
| Return on Assets (ROA) | 3.77% | 6.71% | 7.05% | 7.94% | 7.13% | 6.59% | Upgrade
|
| Return on Invested Capital (ROIC) | 7.85% | 16.91% | 19.22% | 25.16% | 21.45% | 14.78% | Upgrade
|
| Return on Capital Employed (ROCE) | 9.50% | 16.80% | 12.80% | 16.10% | 14.50% | 10.50% | Upgrade
|
| Earnings Yield | 3.37% | 5.27% | 3.78% | 3.57% | 2.35% | 1.14% | Upgrade
|
| FCF Yield | 0.78% | 1.19% | 2.17% | 3.08% | 1.99% | 0.14% | Upgrade
|
| Dividend Yield | 2.90% | 2.69% | 1.11% | 0.77% | - | 1.32% | Upgrade
|
| Payout Ratio | 100.07% | 37.97% | 17.40% | 4.43% | 72.37% | - | Upgrade
|
| Buyback Yield / Dilution | 3.85% | 0.79% | -0.36% | 0.19% | -5.14% | -5.90% | Upgrade
|
| Total Shareholder Return | 6.75% | 3.48% | 0.75% | 0.96% | -5.14% | -4.58% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.